5 months ago
ASRT
AnalystsThomas FlatenThomas Flaten's Stock Forecasts
AnalystsThomas Flaten
Analyst Ranking
Bottom 4%
#4189 out of 4339 analysts
Average Return
-17.08%
Win Rate
18%4 out of 22
Risk vs Reward
Poor
Good
Thomas Flaten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Diamedica Therapeutics IncDMAC | +220.63% | $1.26 | $4.04 | 2022-07-07 - 2023-07-06 | Strong Buy |
Biolife Solutions IncBLFS | +152.95% | $15.77 | $39.89 | 2020-02-24 - 2021-02-24 | Strong Buy |
Castle Biosciences IncCSTL | +40.57% | $11.66 | $16.39 | 2023-06-05 - 2023-09-27 | Strong Buy |
Biolife Solutions IncBLFS | +7.17% | $13.11 | $14.05 | 2023-08-09 - 2023-09-27 | Strong Buy |
Thomas Flaten Analyst Color
Get additional color on Thomas Flaten's coverage of popular stocks
Thomas Flaten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Optinose IncOPTN | 1 | Strong Buy | $3.00 | +140.00% | Initiates Coverage On | a month ago |
Checkpoint Therapeutics IncCKPT | 3 | Strong Buy | $14.00 | +907.19% | Maintains | a month ago |
Better Therapeutics IncBTTX | 2 | Strong Buy | $3.00 | +757.14% | Maintains | 2 months ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $25.00 | +77.94% | Maintains | 2 months ago |
Castle Biosciences IncCSTL | 4 | Strong Buy | $32.00 | +95.24% | Reiterates | 3 months ago |
Achieve Life Sciences IncACHV | 2 | Strong Buy | $19.00 | +341.86% | Maintains | 4 months ago |
Assertio Holdings IncASRT | 2 | Strong Buy | $9.00 | +242.21% | Maintains | 5 months ago |
Evaxion Biotech AEVAX | 1 | Strong Buy | $7.00 | +734.33% | Maintains | 6 months ago |
Oncocyte CorpOCX | 3 | Hold | $10.00 | +219.49% | Downgrades | 10 months ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $960.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.